Skip to main content

Neurable

Category: AI in Healthcare

A neurotechnology platform and consumer wearable ecosystem that integrates brain-computer interface (BCI) sensors into everyday audio devices to track cognitive health and focus. Neurable was founded in 2015. The company is led by Ramses Alcaide. Based in Boston, United States. Team size: 35-50. Total funding raised: $65.0M. Latest round: Series A ($35.0M, Dec 2025). Key investors include ["Spectrum Moonshot Fund","M Ventures","Ultratech Capital Partners","Pace Ventures"].

Founded
2015
Headquarters
Boston, United States
Team size
35-50
Total funding
$65.0M

Value proposition

Transforms standard headphones into smart brain-sensing devices that provide real-time insights into focus, burnout, and cognitive performance without requiring complex medical equipment.

Products and solutions

["MW75 Neuro (Smart BCI Headphones)","Neurable AI (Brain Signal Processing Platform)","Neurable App (Cognitive Health Dashboard)","Research Kit (For academic/commercial R&D)"]

Unique value

Successfully commercialized the first consumer-grade BCI headphone using dry electrodes that require no setup, gel, or invasive procedures, packaged in a premium audio form factor.

Target customer

Knowledge workers, biohackers, enterprise wellness programs, and consumer audio enthusiasts.

Industries served

["Consumer Electronics","Digital Health & Wellness","Enterprise Productivity","Neuroscience Research"]

Technology advantage

Proprietary AI signal processing algorithms capable of denoising EEG data in real-world environments, allowing for accurate cognitive tracking (focus/fatigue) through hair and movement.

How they differentiate

Neurable differentiates by integrating 'invisible' BCI sensors into premium consumer audio headphones (like the MW75 Neuro) rather than requiring dedicated, medical-looking headsets. This 'everyday' form factor allows for passive, continuous cognitive tracking (focus, burnout) without friction.

Main competitors

["Neuralink","Emotiv","Muse (Interaxon)"]

Key partnerships

["Master & Dynamic (Hardware/Manufacturing Partner)","Healthspan Digital (Clinical/Longevity Application)","Spectrum Moonshot Fund (Lead Investor)","Department of Defense (Historical R&D Partner)"]

Notable customers

["Master & Dynamic (Hardware Partner)","Healthspan Digital (Clinical Partner)","Department of Defense (R&D Client)"]

Major milestones

["Launched MW75 Neuro, the first BCI-enabled consumer headphones","Secured $35M Series A led by Spectrum Moonshot Fund in Dec 2025","Partnered with Healthspan Digital to deploy neurotechnology in longevity clinics"]

Growth metrics

Scaled total funding to $65M; Commercialized first smart BCI headphones (MW75 Neuro); Expanded into clinical longevity market via Healthspan Digital partnership.

Market positioning

Consumer-first Neurotech / BCI for Wellness & Productivity

Geographic focus

North America (HQ), Global (Partnerships in Dubai, Canada)

Patents and IP

Holds approximately 19 patents (including 'Brain-computer interface with high-speed eye tracking' and 'Monitoring of biometric data to determine mental states').

About Ramses Alcaide

Dr. Ramses Alcaide is a neuroscientist and electrical engineer. Prior to Neurable, he was a Graduate Student Research Assistant at the University of Michigan's Direct Brain Interface Laboratory, developing BCI technology for rehabilitation. He also served as CEO of Pharo LLC, a technology venture, and holds a Ph.D. in Neuroscience and an M.S. in Electrical Engineering from the University of Michigan.

Official website: